Page last updated: 2024-08-24

aripiprazole and Depressive Disorder

aripiprazole has been researched along with Depressive Disorder in 38 studies

Research

Studies (38)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	19 (50.00)	29.6817
2010's	17 (44.74)	24.3611
2020's	2 (5.26)	2.80

Authors

Authors	Studies
Endo, K; Kodama, W; Terao, I; Tsuge, T	1
Espay, AJ; Gupta, HV; Sharma, VD	1
Alonso, E; Arnott, SR; Atluri, S; Blumberger, D; Brenner, CA; Daskalakis, ZJ; Dhami, P; Dharsee, M; Evans, KR; Farzan, F; Frehlich, M; Frey, BN; Kennedy, SH; Kleffner, K; Lam, RW; Liotti, M; McAndrews, MP; Milev, R; Price, R; Ravindran, A; Rotzinger, S; Vila-Rodriguez, F; Wong, W	1
Beyer, JL; Johnson, KG	1
Aleixo, A; Capeto Coelho, I; Linhares, L; Martins, A; Telles Correia, D	1
Chhatlani, A; Farheen, SA; Setty, MJ; Tampi, RR	1
Ahmad, R; Mathews, M; Mathews, N; Menon, N; Papa-Molter, A	1
Pitchot, W	1
Jago, BJ	1
Adham, N; Gruca, P; Gyertyán, I; Kiss, B; Lasoń-Tyburkiewicz, M; Papp, M	1
Connolly, JG; Schneeweiss, MC; Toomey, TJ	1
Aizenstein, HJ; Andreescu, C; Butters, MA; Karim, HT; Karp, JF; Reynolds, C; Smagula, SF; Tudorascu, D	1
Chen, CY; Hou, YC; Lai, CH; Wu, YT	1
Nelson, R; Pumariega, AJ; Rotenberg, L	1
Ghaemi, SN; Rakofsky, JJ	1
Terao, T	1
Jana, AK; Praharaj, SK; Sinha, VK	1
Bies, R; Devlin, B; Dew, MA; Driscoll, HC; Lenze, EJ; Lotrich, F; Mulsant, BH; Pollock, BG; Reynolds, CF; Sheffrin, M	1
Dom, G; Komen, G; Van Den Eede, F	1
Carson, WH; Chang, K; Findling, RL; Forbes, RA; Ivanova, S; Iwamoto, T; Jin, N; McQuade, RD; Nyilas, M	1
Campanella, D; De Berardis, D; Di Giannantonio, M; Marasco, V; Moschetta, FS; Serroni, N	1
Rittmannsberger, H; Werl, R	1
Capapey, J; Colom, F; Goikolea, JM; Grande, I; Sanchez-Moreno, J; Torres, I; Undurraga, J; Valentí, M; Vieta, E	1
Plotnikoff, GA	1
Almeida, JR; Axelson, DA; Birmaher, B; Diler, RS; Ladouceur, CD; Pan, LA; Phillips, ML; Segreti, A	1
Carson, WH; Kitagawa, H	1
Oberpichler-Schwenk, H	1
Kinrys, G; Pollack, MH; Worthington, JJ; Wygant, LE	1
Duggal, HS; Kithas, J	1
Adson, DE; Fahnhorst, TA; Kushner, MG	1
Caroff, SN; Hammerman, S; Lam, C	1
Devanand, D; Eisenstadt, R; Miyazaki, M; Roose, S; Rutherford, B; Sackeim, H; Sneed, J	1
Arnaout, B; Batchelder, S; Coram, L; Corpuz, V; Hellerstein, DJ; Hyler, S; Weiss, G	1
Blow, FC; Cassidy, KA; Coconcea, N; Hays, RW; Ignacio, RV; Meyer, WJ; Sajatovic, M	1
Masand, PS; Pae, CU; Patkar, AA; Serretti, A	1
Sokolski, KN	1

Reviews

6 review(s) available for aripiprazole and Depressive Disorder

Article	Year
Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: A systematic review and network meta-analysis Journal of affective disorders, 2024, Feb-01, Volume: 346 Topics: Adult; Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Humans; Ketamine; Lithium; Network Meta-Analysis	2024
Advances in Pharmacotherapy of Late-Life Depression. Current psychiatry reports, 2018, 04-07, Volume: 20, Issue:5 Topics: Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder; Drug Resistance; Duloxetine Hydrochloride; Humans; Paroxetine; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vortioxetine	2018
Use of cariprazine in psychiatric disorders: A systematic review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2018, Volume: 30, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder; Humans; Piperazines; Risperidone; Schizophrenia	2018
Incomplete response in late-life depression: getting to remission. Dialogues in clinical neuroscience, 2008, Volume: 10, Issue:4 Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Clinical Trials as Topic; Depressive Disorder; Drug Therapy, Combination; Humans; Mental Disorders; Piperazines; Quinolones; Treatment Outcome	2008
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol. Journal of affective disorders, 2013, Jan-25, Volume: 144, Issue:3 Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Industry; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Support as Topic; Risperidone; Thiazoles	2013
Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence. CNS drugs, 2008, Volume: 22, Issue:5 Topics: Animals; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Depressive Disorder; Humans; Piperazines; Quinolones	2008

Trials

5 trial(s) available for aripiprazole and Depressive Disorder

Article	Year
Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:10 Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Child, Preschool; Comorbidity; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome	2009
Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients. International clinical psychopharmacology, 2005, Volume: 20, Issue:1 Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Depressive Disorder; Drug Resistance; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	2005
Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors. Journal of affective disorders, 2005, Volume: 86, Issue:1 Topics: Adult; Aged; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Comorbidity; Depressive Disorder; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2005
Aripiprazole as an adjunctive treatment for refractory unipolar depression. Progress in neuro-psychopharmacology & biological psychiatry, 2008, Apr-01, Volume: 32, Issue:3 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Brief Psychiatric Rating Scale; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Quinolones; Social Behavior; Time Factors; Treatment Outcome	2008
Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:1 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Bipolar Disorder; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Female; Humans; Interview, Psychological; Lamotrigine; Lithium Carbonate; Male; Middle Aged; Pilot Projects; Piperazines; Prospective Studies; Quinolones; Triazines; Valproic Acid	2008

Other Studies

27 other study(ies) available for aripiprazole and Depressive Disorder

Article	Year
Copulatory Dyskinesia: Pathognomonic Manifestation of Tardive Dyskinesia. Tremor and other hyperkinetic movements (New York, N.Y.), 2020, 12-16, Volume: 10 Topics: Adrenergic beta-Antagonists; Aged; Aripiprazole; Clonazepam; Deprescriptions; Depressive Disorder; Drug Substitution; GABA Modulators; Humans; Male; Parkinsonian Disorders; Pelvis; Propranolol; Quinolones; Serotonin Agents; Tardive Dyskinesia; Tetrabenazine; Thiophenes; Treatment Failure; Valine	2020
Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression. Scientific reports, 2017, 08-07, Volume: 7, Issue:1 Topics: Access to Information; Antidepressive Agents; Aripiprazole; Brain Mapping; Canada; Citalopram; Data Curation; Depressive Disorder; Electroencephalography; Guidelines as Topic; Humans; Medical Informatics Computing; Problem Solving; Research Design; Research Personnel; Treatment Outcome	2017
Hemolytic anemia potentially associated with aripiprazole. Psychiatry and clinical neurosciences, 2018, Volume: 72, Issue:12 Topics: Anemia, Hemolytic; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder; Female; Humans; Middle Aged	2018
Hiccups With Dose Titration of Aripiprazole. The primary care companion for CNS disorders, 2018, 11-22, Volume: 20, Issue:6 Topics: Antidepressive Agents; Aripiprazole; Depressive Disorder; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Hiccup; Humans; Middle Aged	2018
[Is there a place for the physician's hopelesness in the treatment of depression?]. Revue medicale de Liege, 2013, Volume: 68, Issue:2 Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Chronic Disease; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Duloxetine Hydrochloride; Humans; Male; Middle Aged; Physician's Role; Piperazines; Quinolones; Remission Induction; Risk Factors; Thiophenes; Treatment Outcome	2013
My sleep fest: an autoethnographic short story. Health communication, 2015, Volume: 30, Issue:1 Topics: Anthropology, Cultural; Antipsychotic Agents; Aripiprazole; Clonazepam; Depressive Disorder; GABA Modulators; Humans; Inappropriate Prescribing; Quetiapine Fumarate; Sleep	2015
Attenuation of anhedonia by cariprazine in the chronic mild stress model of depression. Behavioural pharmacology, 2014, Volume: 25, Issue:5-6 Topics: Anhedonia; Animals; Antidepressive Agents; Aripiprazole; Chronic Disease; Depressive Disorder; Dietary Sucrose; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Behavior; Imipramine; Male; Piperazines; Quinolones; Rats, Wistar; Stress, Psychological	2014
Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011. Psychiatric services (Washington, D.C.), 2015, Volume: 66, Issue:6 Topics: Adolescent; Affective Disorders, Psychotic; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Blood Glucose; Child; Child, Preschool; Cohort Studies; Conduct Disorder; Databases, Factual; Depressive Disorder; Diabetes Mellitus; Female; Glycated Hemoglobin; Guideline Adherence; Humans; Hyperkinesis; Male; Mass Screening; Mental Disorders; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Thiazoles	2015
Editorial. The journal of mental health policy and economics, 2015, Volume: 18, Issue:4 Topics: Antidepressive Agents; Anxiety Disorders; Aripiprazole; Cost-Benefit Analysis; Cross-Cultural Comparison; Delayed-Action Preparations; Depressive Disorder; Drug Costs; Humans; Injections, Intramuscular; Insurance Coverage; Insurance, Pharmaceutical Services; Schizophrenia	2015
Intrinsic functional connectivity in late-life depression: trajectories over the course of pharmacotherapy in remitters and non-remitters. Molecular psychiatry, 2017, Volume: 22, Issue:3 Topics: Aged; Aripiprazole; Brain; Brain Mapping; Depression; Depressive Disorder; Executive Function; Female; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Neuropsychological Tests; Parietal Lobe; Rest; Temporal Lobe; Venlafaxine Hydrochloride	2017
Gray matter increases in fronto-parietal regions of depression patients with aripiprazole monotherapy: An exploratory study. Medicine, 2016, Volume: 95, Issue:34 Topics: Adult; Antipsychotic Agents; Aripiprazole; Case-Control Studies; Cerebral Cortex; Depressive Disorder; Female; Gray Matter; Humans; Magnetic Resonance Imaging; Male	2016
Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression. CNS spectrums, 2008, Volume: 13, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Benzazepines; Bipolar Disorder; Depressive Disorder; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotherapy; Quinolones; Quinoxalines; Smoking Cessation; Stress, Psychological; Varenicline	2008
Is aripiprazole an efficacious adjunct for unipolar depression? The Journal of clinical psychiatry, 2008, Volume: 69, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Depressive Disorder; Drug Therapy, Combination; Humans; Piperazines; Quinolones; Treatment Outcome	2008
Unusual weight fluctuation under corticosteroid and psychotropic treatment. Psychiatry and clinical neurosciences, 2008, Volume: 62, Issue:5 Topics: Adult; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Appetite; Aripiprazole; Body Weight; Cyclosporine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Eating; Female; Humans; Mianserin; Paroxetine; Piperazines; Prednisolone; Quinolones; Sertraline; Takayasu Arteritis	2008
Aripiprazole-induced sialorrhea. Progress in neuro-psychopharmacology & biological psychiatry, 2009, Mar-17, Volume: 33, Issue:2 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder; Humans; Male; Piperazines; Quinolones; Sialorrhea; Valproic Acid	2009
[Aripiprazole and acute dystonia]. Tijdschrift voor psychiatrie, 2009, Volume: 51, Issue:10 Topics: Acute Disease; Antipsychotic Agents; Aripiprazole; Depressive Disorder; Dystonia; Female; Humans; Piperazines; Product Surveillance, Postmarketing; Quinolones; Young Adult	2009
A case of Cotard's Syndrome successfully treated with aripiprazole monotherapy. Progress in neuro-psychopharmacology & biological psychiatry, 2010, Oct-01, Volume: 34, Issue:7 Topics: Antipsychotic Agents; Aripiprazole; Delusions; Depressive Disorder; Female; Humans; Piperazines; Quinolones; Young Adult	2010
Does aripiprazole protect from serotonin syndrome? Psychiatria Danubina, 2012, Volume: 24, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Tremor; Venlafaxine Hydrochloride; Young Adult	2012
Drug-nutrient interactions: a case and clinical guide. Minnesota medicine, 2011, Volume: 94, Issue:10 Topics: Alcohol Drinking; Antipsychotic Agents; Aripiprazole; Combined Modality Therapy; Depressive Disorder; Dietary Supplements; Food; Food-Drug Interactions; Humans; Male; Malnutrition; Middle Aged; Piperazines; Prescription Drugs; Quinolones	2011
Neural correlates of treatment response in depressed bipolar adolescents during emotion processing. Brain imaging and behavior, 2013, Volume: 7, Issue:2 Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Citalopram; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Emotions; Facial Expression; Female; Humans; Lamotrigine; Magnetic Resonance Imaging; Male; Piperazines; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Sertraline; Triazines; Valproic Acid	2013
Medication developments in the treatment of mental illness. Behavioral healthcare tomorrow, 2003, Volume: 12, Issue:6 Topics: Adolescent; Aged; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Blood Glucose; Child; Depressive Disorder; Humans; Mental Disorders; Piperazines; Primary Health Care; Quinolones; Schizophrenia; Selective Serotonin Reuptake Inhibitors	2003
Drug development for anxiety disorders: new roles for atypical antipsychotics. Psychopharmacology bulletin, 2004,Winter, Volume: 38, Issue:1 Topics: Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Depressive Disorder; Drug Therapy, Combination; Humans	2004
[Aripiprazol. An atypical neuroleptic with exceptional mechanisms of action] ]. Medizinische Monatsschrift fur Pharmazeuten, 2004, Volume: 27, Issue:11 Topics: Antipsychotic Agents; Aripiprazole; Clinical Trials as Topic; Depressive Disorder; Dopamine Agonists; Humans; Piperazines; Quinolones	2004
Possible neuroleptic malignant syndrome with aripiprazole and fluoxetine. The American journal of psychiatry, 2005, Volume: 162, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Depressive Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Male; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors	2005
Neuroleptic malignant syndrome and aripiprazole. Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:6 Topics: Adolescent; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder; Female; Humans; Intellectual Disability; Lorazepam; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; United States	2006
An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression. International journal of geriatric psychiatry, 2007, Volume: 22, Issue:10 Topics: Age of Onset; Aged; Aged, 80 and over; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2007
Adjunctive aripiprazole for bupropion-resistant major depression. The Annals of pharmacotherapy, 2008, Volume: 42, Issue:7 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Bupropion; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Quinolones	2008